World Hepatitis Alliance 279d ago

A hybrid side-event, held Tuesday 23 September 2025 in New York, ahead of the fourth UN High-Level Meeting on NCDs. Liver cancer claims almost a million lives each year. Chronic viral hepatitis is its leading cause. This unique interactive session brings together stakeholders from across the political and global health landscape to discuss how the ‘Patient Charter to Improve Care for Hepatocellular Carcinoma’ and the World Hepatitis Alliance’s recent white paper, ‘Beating cancer through hepatitis elimination – working together to reduce NCDs’ can drive change. Featuring guest speakers: • Danjuma Adda, Executive Director, CFID Taraba and Chagro-Care Trust • Anamaria Bejar, Director – Public Policy Engagement, Gavi, the Vaccine Alliance • Rachel Halford, President, World Hepatitis Alliance (Chair) • Prof Mohamed Hassany, Assistant Minister of Health for Public Health Initiatives, Egypt • Jessica Hicks, Senior Director, World Hepatitis Alliance • Cary James, Chief Executive, World Hepatitis Alliance • Eliana Monteforte, Director of International Advocacy and Engagement, Global Health Council and Advisory Group Member of the Civil Society Engagement Mechanism (CSEM) for UHC2030 • Dr Zainab Shinkafi-Bagudu, President-elect, UICC • Lujing Wang, MD, MPH, Managing Partner, Acsel Health With support from AstraZeneca